Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives of Neurology

• Publication date

  2003-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.60.8.1073PMID 12925362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain

  2004influential reference
• The clinico‐radiological paradox in multiple sclerosis revisited

  2002cited by this paper
• Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

  2002cited by this paper
• Slowing of voluntary and involuntary saccades: An early sign in spinocerebellar ataxia type 7

  2001cited by this paper
• Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions.

  2001cited by this paper
• Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.

  2000cited by this paper
• Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

  2000cited by this paper
• Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

  2000cited by this paper
• Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS

  2000cited by this paper
• NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions

  2000cited by this paper
• Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.

  2000cited by this paper
• Patients with active relapsing‐remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination

  2000cited by this paper
• IV immunoglobulin does not reverse established weakness in MS

  2000cited by this paper
• In vivo evaluation of remyelination in rat brain by magnetization transfer imaging.

  2000cited by this paper
• Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability

  1999cited by this paper
• Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

  1999cited by this paper
• A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.

  1999cited by this paper
• Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

  1999cited by this paper
• Therapeutic strategies in multiple sclerosis. II. Long-term repair.

  1999influential reference
• Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.

  1999cited by this paper
• The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

  1999cited by this paper
• Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

  1998cited by this paper
• Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.

  1998cited by this paper
• Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells

  1998cited by this paper
• Early structural changes in acute MS lesions assessed by serial magnetization transfer studies

  1998cited by this paper
• Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus).

  1998cited by this paper
• Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis

  1998cited by this paper
• Axonal transection in the lesions of multiple sclerosis.

  1998cited by this paper
• Remyelination in multiple sclerosis

  1997cited by this paper
• Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology

  1997cited by this paper
• Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.

  1997cited by this paper
• Imaging of remyelination

  1997cited by this paper
• Induction of nitric oxide synthase in multiple sclerosis lesions

  1997cited by this paper
• Immunocytochemical Characterization of the Expression of Inducible and Constitutive Isoforms of Nitric Oxide Synthase in Demyelinating Multiple Sclerosis Lesions

  1997cited by this paper
• Monocyte/macrophage differentiation in early multiple sclerosis lesions

  1995cited by this paper
• Spontaneous and induced remyelination in multiple sclerosis and the theiler's virus model of central nervous system demyelination

  1995cited by this paper
• Oligodendrocytes in the early course of multiple sclerosis

  1994cited by this paper
• Multiple Sclerosis: Remyelination in Acute Lesions

  1993cited by this paper
• A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to myelination

  1993cited by this paper
• Improved vision after intravenous immunoglobulin in stable demyelinating optic neuritis

  1992cited by this paper
• Remyelination in multiple sclerosis

  1978cited by this paper

• Transcriptional Heterogeneity Reveals a Synaptic Gene Program in Developing and Adult Human Oligodendrocyte Precursor Cells

  2026cites this paper
• The Road to Remyelination in Multiple Sclerosis: Breakthroughs, Challenges, and Considerations for Future Trial Design

  2025cites this paper
• Endogenous Repair in Vanishing White Matter

  2025cites this paper
• Ageing and remyelination failure in people with multiple sclerosis

  2025cites this paper
• Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature review.

  2025cites this paper
• Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

  2024cites this paper
• The Study of Remyelinating Therapies in Multiple Sclerosis: Visual Outcomes as a Window Into Repair

  2024cites this paper
• Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis

  2024cites this paper
• Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis

  2024cites this paper
• q‐Space Myelin Map: A new myelin‐specific imaging technique for treatment monitoring of multiple sclerosis

  2024cites this paper
• Examining the relative contribution of slow-burning inflammation and chronic demyelination to axonal damage in chronic multiple sclerosis lesions.

  2024cites this paper
• Magnetization Transfer Contrast - Is it Sensitive Enough to Differentiate Demyelination from Axonal Loss?

  2023cites this paper
• Women in the field of multiple sclerosis: How they contributed to paradigm shifts

  2023cites this paper
• MR myelin imaging in multiple sclerosis: A scoping review.

  2023cites this paper
• CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.

  2023cites this paper
• Utility of Diffusion and Magnetization Transfer MRI in Cervical Spondylotic Myelopathy: A Pilot Study

  2022cites this paper
• Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study

  2022cites this paper
• Recent insights into astrocytes as therapeutic targets for demyelinating diseases.

  2022cites this paper
• Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis

  2022cites this paper
• Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis

  2022cites this paper
• Remyelination varies between and within lesions in multiple sclerosis following bexarotene

  2022cites this paper
• Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics

  2022cites this paper
• Changes in thumb tapping rates and central motor conduction times are associated in persons with multiple sclerosis

  2022cites this paper
• From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions

  2022cites this paper
• Neurodegeneration in multiple sclerosis

  2022cites this paper
• Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio

  2022cites this paper
• Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis

  2022cites this paper
• Periventricular magnetisation transfer abnormalities in early multiple sclerosis

  2022cites this paper
• Cell‐based experimental strategies for myelin repair in multiple sclerosis

  2022cites this paper
• T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

  2022cites this paper
• Human Structural MRI

  2021cites this paper
• Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review

  2021cites this paper
• Mechanisms of myelin repair, MRI techniques and therapeutic opportunities in multiple sclerosis.

  2021cites this paper
• Pathology of Multiple Sclerosis

  2021cites this paper
• Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?

  2021cites this paper
• Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis

  2021cites this paper
• The Ins and Outs of Central Nervous System Inflammation-Lessons Learned from Multiple Sclerosis.

  2021cites this paper
• Low field magnetic stimulation promotes myelin repair and cognitive recovery in chronic cuprizone mouse model

  2021cites this paper
• Imaging and therapy in multiple sclerosis

  2020cites this paper
• In vivo imaging of chronic active lesions in multiple sclerosis

  2020cites this paper
• Stem Cell-based Therapy for Neurodegenerative Diseases

  2020cites this paper
• Stem Cells Therapy for Multiple Sclerosis.

  2020cites this paper
• Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS

  2020cites this paper
• Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions

  2020cites this paper
• Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies

  2020cites this paper
• Effects of Low Field Magnetic Stimulation on Cognitive Impairment and Brain Pathologies in the Cuprizone Mouse Model of Demyelination

  2020cites this paper
• Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions

  2020cites this paper
• Understanding the Radiologist's Role in Evaluating Multiple Sclerosis: A Review of the Tip of the Iceberg.

  2020cites this paper
• Three‐Dimensional Lesion Phenotyping and Physiologic Characterization Inform Remyelination Ability in Multiple Sclerosis

  2019cites this paper
• Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination

  2019influential citation
• Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis.

  2019cites this paper
• Recent Developments of Diagnostic Criteria in Multiple Sclerosis

  2019cites this paper
• Prognostic value of white matter lesion shrinking in early multiple sclerosis: An intuitive or naïve notion?

  2019cites this paper
• Quantitative Imaging of White and Gray Matter Remyelination in the Cuprizone Demyelination Model Using the Macromolecular Proton Fraction

  2019cites this paper
• Myelin in the Central Nervous System: Structure, Function, and Pathology.

  2019cites this paper
• Gait rehabilitation using the Huber 360 platform in multiple sclerosis

  2019cites this paper
• Developing therapeutic strategies to promote myelin repair in multiple sclerosis

  2019cites this paper
• Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS

  2019cites this paper
• Imaging in mice and men: pathophysiological insights into multiple sclerosis from conventional and advanced MRI techniques.

  2019cites this paper
• Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach

  2019cites this paper
• Phases and Phenotypes of Multiple Sclerosis.

  2019cites this paper
• Long‐Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions

  2018cites this paper
• Vitamin K enhances the production of brain sulfatides during remyelination

  2018cites this paper
• Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple Sclerosis

  2018cites this paper
• Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques

  2018cites this paper
• Magnetic resonance imaging correlates of neuro‐axonal pathology in the MS spinal cord

  2018cites this paper
• Progressive Forms of Multiple Sclerosis: Distinct Entity or Age-Dependent Phenomena.

  2018cites this paper
• Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology

  2018cites this paper
• Quantifying multiple sclerosis pathology in post mortem spinal cord using MRI

  2018cites this paper
• Postmortem magnetic resonance imaging.

  2018cites this paper
• Dark Rims: Novel Sequence Enhances Diagnostic Specificity in Multiple Sclerosis

  2018cites this paper
• Pathophysiological basis of low contrast visual acuity loss in multiple sclerosis

  2018cites this paper
• MRI spectra detect myelin differences between types of multiple sclerosis lesions

  2018cites this paper
• Brain and cervical cord myelin water imaging in neuromyelitis optica spectrum disorder

  2018cites this paper
• Cortical Remyelination Is Heterogeneous in Multiple Sclerosis

  2017cites this paper
• Remyelination in multiple sclerosis: Pathology and treatment strategies

  2017cites this paper
• Microstructural MR Imaging Techniques in Multiple Sclerosis.

  2017cites this paper
• q-space Myelin Map imaging: A new imaging technique for treatment evaluation in multiple sclerosis.

  2017cites this paper
• Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study

  2017influential citation
• MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.

  2017cites this paper
• White Matter Plasticity in the Adult Brain

  2017cites this paper
• MicroRNA profiling of multiple sclerosis: from brain to blood

  2017cites this paper
• TSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis

  2017cites this paper
• T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis

  2017influential citation
• Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials

  2017cites this paper
• Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.

  2017cites this paper
• Remyelination therapies: a new direction and challenge in multiple sclerosis

  2017cites this paper
• q-Space Myelin Map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: A preliminary study.

  2017cites this paper
• Serial MRI Analysis to Track Long-term Evolution of White Matter Lesions in Multiple Sclerosis

  2017cites this paper
• Axonal Loss and Neurodegeneration in Multiple Sclerosis

  2017cites this paper
• Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter

  2017cites this paper
• Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?

  2016cites this paper
• Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types

  2016cites this paper
• Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study

  2016cites this paper
• Role of Neuroimaging in Multiple Sclerosis

  2016cites this paper
• Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis

  2016cites this paper
• Alterations in brain white matter contributing to age‐related slowing of task switching performance: The role of radial diffusivity and magnetization transfer ratio

  2016cites this paper
• Alterations in Brain White Matter Contributing to AgeRelated Slowing of Task Switching Performance

  2016cites this paper
• A practical review of the neuropathology and neuroimaging of multiple sclerosis

  2016cites this paper
• Diffusion Tensor Imaging in Acute Optic Neuropathies

  2016cites this paper